I
PTCT icon

InceptionR’s PTC Therapeutics PTCT Stock Holding History

InceptionR’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,115
Closed -$321K – 779
2024
Q4 		$321K Sell
7,115
-1,567
-18% -$67.1K 0.07% 437
2024
Q3 		$322K Buy
+8,682
New +$291K 0.08% 435
2024
Q2 		– Sell
-11,694
Closed -$340K – 804
2024
Q1 		$340K Buy
+11,694
New +$328K 0.09% 389

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

InceptionR's PTCT Position: Q1 2025 in Review

InceptionR sold out of PTC Therapeutics (PTCT) in Q1 2025, closing a stake of 7,115 shares — an estimated $321K sold.

InceptionR first reported a position in PTCT in Q1 2024 and held it in 3 quarters. The position peaked at $340K in Q1 2024. 260 funds tracked by Wall St. Rank hold PTCT as of Q1 2025.

  • InceptionR reported no remaining PTC Therapeutics position as of Q1 2025 after selling out during the quarter.
  • InceptionR sold 7,115 PTC Therapeutics shares in Q1 2025, an estimated $321K.
  • InceptionR first reported a position in PTC Therapeutics in Q1 2024 and held it in 3 quarters.
  • InceptionR's PTC Therapeutics position peaked at $340K in Q1 2024.
  • 260 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2025.

Based on InceptionR's 13F filing for Q1 2025, filed 12 May 2025.